Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases

QR Code

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases

Latrepirdine (DimebonTM) was originally marketed as a non-selective antihistamine in Russia. It was repurposed as an effective treatment for patients suffering from Alzheimer’s disease (AD) and Huntington’s disease (HD) following preliminary reports showing its neuroprotective functions and ability...

Full description

Bibliographic Details
Main Authors:	Bharadwaj, P., Bates, K., Porter, T., Teimouri, E., Perry, G., Steele, J., Gandy, S., Groth, David, Martins, R., Verdile, G.
Format:	Journal Article
Published:	Nature.com 2013
Subjects:	Alzheimer’s disease mechanism of action latrepirdine
Online Access:	http://hdl.handle.net/20.500.11937/26082

Similar Items

The Effects of Latrepirdine on Amyloid-ß Aggregation and Toxicity
by: Porter, T., et al.
Published: (2016)

Latrepirdine enhances Aß degradation in yeast via an autophagic pathway
by: Bharadwaj, Prashant, et al.
Published: (2010)

Effects of latrepirdine on Aß clearance, neurotoxicity and aggregation
by: Martins, R., et al.
Published: (2010)

Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
by: Steele, J., et al.
Published: (2013)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

Investigating genetic variation in Alzheimer’s disease
by: Patel, Tulsi
Published: (2018)

Understanding haemodynamics in neurodegenerative disease
by: Dury, R.J.
Published: (2018)

Latrepirdine (Dimebon™) enhances autophagy and reduces intracellular GFP-A42 levels in yeast
by: Bharadwaj, P., et al.
Published: (2012)

Default mode network perturbations in Alzheimer's disease: an fMRI study in Klang Valley, Malaysia
by: Mohad Azmi, Nur Hafizah, et al.
Published: (2024)

Investigating polygenic risk scores in Alzheimer's disease
by: Chaudhury, Sultan Raja
Published: (2024)

Consumption of fish and Alzheimer's Disease
by: Newton, Wendy, et al.
Published: (2011)

Evaluation of AChE inhibitors and dual AChE/GSK3-β inhibitor as Alzheimer’s disease treatment
by: Uras, G
Published: (2021)

Translational control of epidermal growth factor receptor in neurodegenerative diseases
by: Smalley, Daniel. S.
Published: (2017)

Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)

Development of an allele-specific polymerase chain reaction genotyping test and association of selected single nucleotide polymorphisms and analytes with the risk of alzheimer’s disease / Mohd Nazif Samat @ Darawi
by: Samat @ Darawi, Mohd Nazif
Published: (2014)

Rationalising the role of Keratin 9 as a biomarker for Alzheimer’s disease
by: Richens, Joanna L., et al.
Published: (2016)

Latrepirdine stimulates autophagy and reduces accumulation of a-synuclein in cells and in mouse brain
by: Steele, J., et al.
Published: (2013)

Neuroprotective effects of thymoquinone-rich fraction and thymoquinone nanoemulsions in sporadic alzheimer’s disease rat model
by: Ismail, Norsharina
Published: (2019)

The Guinea Pig as a Model for Sporadic Alzheimer’s Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes
by: Sharman, Matthew, et al.
Published: (2013)

Prediction of Alzheimer disease using improved MMSE ensemble regressor based on magnetic resonance images
by: Farzan, Ali
Published: (2015)

Exploring block and permeation of N-methyl-D-Aspartate (NMDA) receptor channels for treatment of neurodegenerative disorders
by: Abu, Izuddin Fahmy
Published: (2016)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Reproducibility of gait variability measures in people with Alzheimer's disease
by: Wittwer, J., et al.
Published: (2013)

The effect of memantine and the ladybird alkaloid, harmonine, on NMDA receptor function and Alzheimer’s disease
by: Kaur, Kiran
Published: (2022)

Common polygenic variation can predict risk of Alzheimer’s disease
by: Escott-Price, Valentina, et al.
Published: (2015)

Investigation into patterns of epigenetic regulation of Alzheimer’s disease
by: Boden, Kirsty
Published: (2019)

PHARMACOLOGICAL EVALUATION OF NOVEL COMPOUNDS AS ALZHEIMER’S DISEASE TREATMENT
by: Li, Tian-Tian
Published: (2024)

Calculating polygenic risk score for individuals with sporadic early onset Alzheimer’s disease
by: Chaudhury, Sultan R
Published: (2017)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Tracking elderly Alzheimer's patient with radio frequency localization system
by: Abuhan, Mohd Fadhil
Published: (2012)

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor
by: Xie, Ling, et al.
Published: (2002)

A study of the neurodegenerative mechanisms of Alzheimer’s and Huntington’s diseases
by: Parry, Nicholas
Published: (2016)

The structure and function of Alzheimer's gamma secretase enzyme complex
by: Krishnaswamy, S., et al.
Published: (2009)

Identification of functional variants in the Alzheimer’s disease candidate gene ABCA7
by: Clement, Naomi Susan
Published: (2017)

Molecular simulation between amyloid beta (1-42), a Peptide associated with alzheimer disease, and zinc(ii) ion
by: Abdul Ghani, Nur Syafiqah
Published: (2016)

A longitudinal study of change in falls risk and balance and mobility in healthy older people and people with Alzheimer disease
by: Suttanon, P., et al.
Published: (2013)

The effect of Thymosine-ß4 on macrophage phenotype in Alzheimer’s disease
by: Hussain, Ikra
Published: (2019)

Alternative splicing and the inhibition of splicing kinases in Alzheimer’s Disease
by: Alalwany, Roaa
Published: (2021)

Potential of phytochemicals as a treatment for Alzheimer’s disease: evaluation of anticholinesterase activity, antioxidant properties, and cytotoxicity
by: Aljadaan, Adel
Published: (2025)

Cannot write session to /tmp/vufind_sessions/sess_vhldp3n9475aa4at2vru8gv9nk